JADE CURY MARTINS ASFORA LINS

(Fonte: Lattes)
Índice h a partir de 2011
9
Projetos de Pesquisa
Unidades Organizacionais
Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas, Faculdade de Medicina - Médico
LIM/56 - Laboratório de Investigação em Dermatologia e Imunodeficiências, Hospital das Clínicas, Faculdade de Medicina

Resultados de Busca

Agora exibindo 1 - 10 de 42
  • conferenceObject
    Real-world study of the use of pegylated interferon alfa for treatment of primary cutaneous T-cell lymphomas: an EORTC CLTF study
    (2022) MITSUNAGA, K.; BAGOT, M.; BEYLOT-BARRY, M.; RAM-WOLFF, C.; GUENOVA, E.; FASSNACHT, C.; HODAK, E.; AMITAY, I.; PAPADAVID, E.; JONAK, C.; PORKERT, S.; SCARISBRICK, J.; APPLEWAITE, R.; NICOLAY, J.; QUAGLINO, P.; SANCHES JR., J.; MARTINS, J. Cury; ORTIZ-ROMERO, P. L.
  • conferenceObject
    Analysis of clonal immunoglobulin chain gene rearrangement by the technique of polymerase chain reaction (PCR) to aid in the diagnosis of B-cell cutaneous lymphoproliferative processes
    (2023) GUIMARAES, Adriana Borba; SANCHES JUNIOR, Jose Antonio; ZERBINI, Maria Claudia; MIYASHIRO, Denis Ricardo; CURY-MARTINS, Jade; PEREIRA, Juliana; CULLER, Hebert Fabricio; CASTRO, Bruno
  • article 21 Citação(ões) na Scopus
    Chronic activation profile of circulating CD8+T cells in Sezary syndrome
    (2018) TORREALBA, Marina Passos; MANFRERE, Kelly Cristina; MIYASHIRO, Denis R.; LIMA, Josenilson F.; OLIVEIRA, Luana de M.; PEREIRA, Natalli Z.; CURY-MARTINS, Jade; PEREIRA, Juliana; DUARTE, Alberto J. S.; SATO, Maria N.; SANCHES, Jose A.
    Sezary syndrome (SS) is a leukemic variant of cutaneous T cell lymphoma (CTCL), and the neoplastic CD4+ T cells of SS patients undergo intense clonal proliferation. Although Sezary cells have been studied extensively, studies on adaptive immunity regarding CD8+ T cells are scarce. This study aimed to investigate activation marker expression in CD8+ T cells according to the differentiation stages and IL-7/IL7Ra axis responses of patients with SS. Moreover, this study aimed to verify the soluble forms of CD38, sCD127 and IL-7 in serum. Although the SS patients of our cohort had reduced numbers of CD8+ T cells, they exhibited higher percentages of CD8+CD38+T cells, mainly effector/memory CD8+ T cells, than the control group. In contrast, down-regulated expression of the activation markers CD127/IL-7R and CD26 was found in the CD8+ T cells of SS patients. High serum levels of sCD38 and sCD127 and scarce serum levels of IL-7 were detected, emphasizing the immune activation status of SS patients. Moreover, CD8+ T cells from SS patients exhibited IL-7 unresponsiveness to STAT5 phosphorylation and Bcl-2 expression, and IL-7 priming partially restored IFN gamma production. Our findings showed a chronic activation profile of CD8+ T cells, as an attenuated cytotoxic profile and impaired IL-7 responsiveness was observed, suggesting chronic activation status of CD8+ T cells in SS patients.
  • article 0 Citação(ões) na Scopus
    Image-guided lymph node core needle biopsy in mycosis fungoides/Sezary syndrome: Direct comparison to surgical excision
    (2022) CURY-MARTINS, Jade; COUTO NETTO, Sergio Dias do; CASTRO, Stephanie Catarine Carqueijo de; SIQUEIRA, Sheila Aparecida Coelho; GIANNOTTI, Marcelo Abrantes; ZERBINI, Maria Claudia Nogueira; PEREIRA, Juliana; CULLER, Hebert; TEIXEIRA JR., Frederico Jose Ribeiro; MENEZES, Marcos Roberto de; SANCHES, Jose Antonio
  • conferenceObject
    Blastic plasmocytoid dendritic cell neoplasm: a series of fourteen cases from a reference center in Brazil
    (2019) CURY-MARTINS, J.; OLIVEIRA, I. F.; MIYASHIRO, D.; PEREIRA, J.; ABDO, A. N. R.; ZERBINI, M. C.; GIANNOTTI, M. A.; SANCHES, J. A.
  • bookPart
    Histiocitoses
    (2022) TORMENA, Camila Cristina; LINS, Jade Cury Martins Asfora
  • bookPart
    Doenças Sexualmente Transmissiveis
    (2017) DEAK, Elizabeth; TSO, Fernanda Kesselring; MARTINS, Jade Cury; SHIRATSU, Ricardo
  • conferenceObject
    Peripheral T cell lymphoma, not otherwise specified involving the skin: is it always aggressive?
    (2019) CURY-MARTINS, J.; SANCHES, J. A.; CARVALHO, C. H. C.; MIYASHIRO, D.; LAGE, L. A. P. C.; ZERBINI, M. C.; GIANNOTTI, M. A.; PEREIRA, J.
  • article 5 Citação(ões) na Scopus
    Extra-acral cutaneous sclerosing perineurioma with CD34 fingerprint pattern
    (2017) MACARENCO, Ricardo S.; CURY-MARTINS, Jade
    Sclerosing perineuroma is a variant of extraneural perineurioma that, as a rule, occurs in acral sites. However, it has also been occasionally reported in non-acral regions. Recently, CD34 expression in a pattern reminiscent of the human fingerprint has been observed in a subset of perineuriomas, but this immunohistochemical finding has not been documented in non-acral sclerosing perineuriomas. We report a case of sclerosing perineurioma presenting CD34 expression in a fingerprint-like pattern on the skin of the neck (a previously unreported site for this neoplasm) of a 56-year-old man. In addition, alpha smooth-muscle actin showed a similar pattern of expression, suggesting that the cell population implicated in the remarkable immunolabeling is most probably fibroblastic/myofibroblastic. Other immunohistochemical findings included epithelial membrane antigen and claudin1positive lesional cells, and the absence of S100, glucose transporter protein 1, MUC4 and desmin.
  • article 21 Citação(ões) na Scopus
    Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel
    (2020) CURY-MARTINS, Jade; ERIS, Adriana Pessoa Mendes; ABDALLA, Cristina Martinez Zugaib; SILVA, Giselle de Barros; MOURA, Veronica Paula Torel de; SANCHES, Jose Antonio
    With the development of new cancer therapies, systemic toxicity profile and effects on survival achieved an important improvement. However, a constellation of toxicities has emerged, even more remarkably, cutaneous adverse events. This report, developed by a board of Brazilian experts in oncodermatology, aims to establish a guideline for the dermatological care of oncologic patients. When possible, evidence-based recommendations were made, but in many cases, when strong evidence was not available, a consensus was reached, based on some data supporting therapies combined with personal experiences. (C) 2020 Sociedade Brasileira de Dermatologia.